We discuss the recent push to develop support vector machines and other cluster analyses as a means for biological signatures as early screens for autism. These methods not only hold great promise but also require careful consideration prior to implementation. We outline three validity tests and potential methods for addressing them. Autism Res 2011,4:239–241.
No takes yet. Share an insight, caveat, or question.
Yerys et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: